Skip to main navigation Skip to search Skip to main content

Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins

  • Jessyca S. Brito
  • , Natália A. Borges
  • , Marta Esgalhado
  • , DAngelo C. Magliano
  • , Christophe O. Soulage
  • , Denise Mafra
  • Cardiovascular Sciences Graduate Program
  • Medical Sciences Graduate Program
  • Biomedical InstituteFederal University Fluminense
  • Institut national des sciences appliquées Lyon

Research output: Contribution to journalReview articlepeer-review

72 Citations (Scopus)

Abstract

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor involved in the expression of xenobiotic-metabolizing enzymes, inflammatory cytokines and adhesion molecules. Uremic toxins such as indoxyl sulfate and indole acetic acid are derived from tryptophan fermentation by gut microbiota; they accumulate in patients with chronic kidney disease (CKD) on haemodialysis and have recently emerged as potent ligands of AhR. Therefore, AhR can serve as a mediator in inflammation and cardiovascular diseases in these patients. This review discusses current data that support a link between AhR activation and uremic toxins from gut microbiota in CKD.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalNephron
Volume137
Issue number1
DOIs
Publication statusPublished - 1 Aug 2017
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2017 Karger AG, Basel.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Aryl hydrocarbon receptor
  • Chronic kidney disease
  • Inflammation
  • Uremic toxins

Fingerprint

Dive into the research topics of 'Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins'. Together they form a unique fingerprint.

Cite this